Arm Holdings faces legal and regulatory risks, revenue impacts, and overvaluation concerns. Read why ARM shares remain a strong sell.

Among patients with obstructive sleep apnea and excessive daytime sleepiness-related cognitive impairment, 2-week solriamfetol led to cognitive function improvement on three tests/scales, according to ...

Circle, the company behind the USDC stablecoin, has filed for a U.S. initial public offering, becoming the the latest tech ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the beverages, alcohol, and tobacco stocks, including ...

Circle's move to go public signals a pivotal moment for the company and the broader stablecoin system. The USDC backer was ...